Most people should lift roughly double the guideline, about 8 to 12 hard sets per movement pattern each week, because strength, bone and fuel handling benefits keep rising and no study has yet found the ceiling.

• What to do: Train push, pull, squat and hinge with 8 to 12 hard sets per pattern per week, mostly at 65 to 85% of your one rep max, which is a 5 to 12 rep max load, leaving two to four reps in reserve. Add 3 to 5% load when sets feel easier.
• Why it matters: The 2 days a week rule came from a 1989 study where 3 days beat 2 days, and its own authors cited a personal letter from their committee chair. Once volume is equal, frequency barely matters, so total weekly work is the real dose.
• How to apply it: Pick compound exercises you like and can load, and split the work however your schedule allows. Aim for targets: a leg press of about 2.5 times body weight for men and 2 times for women.
• Metrics: Spine bone density rose 2.9% in a trial using five sets of five at about 85% of one rep max twice weekly for 8 months, while controls lost 1.2%. Insulin sensitivity boosts last only 1 to 3 days, so keep training.
• Risks: Injury rates are 2 to 4 per thousand hours, below running, and most injuries resolve in under 2 weeks. Heart damage seen in lifters comes from anabolic steroids, not lifting.
• Exceptions: Muscle mass on a DEXA scan did not predict falls, fractures or death, so function and strength matter more than size.

Three platforms analyzed the same two coronary CT scans and reported plaque changes of minus 48%, plus 20% and nearly flat (10.4 to 11.5 cubic millimeters), because with very little plaque and only 16.5 months between scans, measurement noise looks like a result.

• What to do: If you track plaque with coronary CT angiography, use the same provider, the same scanner and the same settings every time, and wait at least 2 to 5 years between scans, as the American College of Cardiology statement suggests.
• Why it matters: Plaque depends on cumulative exposure to ApoB, the protein on each atherogenic particle, so years at an LDL of about 125 matter even after a diet change, and no platform showed rapid progression (1 percentage point or more per year).
• How to apply it: Ask your doctor about your ApoB target, since he is aiming for 40 mg/dL or lower with Repatha (evolocumab) after sitting at 70 to 80 on a plant based diet, and keep training, sleep and diet in place.
• Metrics: ApoB 70 to 80 mg/dL, LDL 125 before diet change, calcium score 4, soft plaque down about 40% on Qangio, and a reading near the 55th percentile on Clearly versus the 80th on HeartFlow.
• Tools: Qangio, Clearly and HeartFlow for plaque analysis, aged garlic extract at 2,400 mg a day, and Eight Sleep for sleep temperature.
• Risks: AI platforms may overestimate small plaque amounts, and this is one person's plan, not a recommendation.
• Exceptions: Statins remain first line therapy and may fit you better, and some people need two drugs to reach target.

One cup of blueberries a day improves flow mediated dilation by about 1 to 1.5 percentage points, and each extra point is linked to roughly 12% fewer future cardiovascular events, while regular intake is tied to cognitive aging equal to being 1.5 to 2.5 years younger.

• What to do: Eat about one cup of whole fresh or frozen blueberries every day, ideally with a meal or in place of a refined carbohydrate dessert.
• Why it matters: Anthocyanins and the metabolites your gut microbes make from them act as signaling molecules that support nitric oxide, blood vessel function, memory, glucose handling and recovery after hard exercise.
• How to apply it: Add them to yogurt or oatmeal, eat them on their own, or blend them into a smoothie, and aim for a full cup because half a cup did not improve vascular function in a six month trial.
• Metrics: A cup a day improved flow mediated dilation by 1 to 1.5 points, one trial lowered arterial stiffness by 2.24 points, and in insulin resistant adults about two cups improved insulin sensitivity by 22% in one study.
• Risks: Evidence for blood sugar is mixed, since fasting glucose rarely drops and one 8 week replication attempt did not reproduce the insulin sensitivity gain.
• Exceptions: Blending with banana may reduce polyphenol exposure because banana polyphenol oxidase degrades chlorogenic acid and anthocyanins, so the speaker swaps banana for avocado, though no study has tested the effect on blueberry benefits.

Wall sits cut systolic blood pressure by 11 mmHg and diastolic by 5 in a review of 270 trials and 15,000 people, more than double what walking does, because holding the contraction triggers a nitric oxide surge and an insulin independent glucose uptake in the large leg muscles.

• What to do: Hold a wall sit with thighs parallel to the floor for as long as you can, building to 2 minutes. Do it two to three times per week for about a month, then once a week to maintain.
• Why it matters: Isometrics lowered systolic pressure by 8 mmHg as a category versus about 5 for cardio and resistance training and 4 for intervals. Total work time is only 10 to 12 minutes.
• How to apply it: Do a wall sit 15 to 30 minutes after your highest carbohydrate meal so AMPK pulls glucose into muscle without insulin, then add a walk. At a desk, hold a hand grip at 30% of max for 2 minutes and rest 1 minute.
• Metrics: Under 1 hour per week of isometrics dropped systolic by 10.4 and diastolic by 6.7. In 77 adults off medication, systolic fell 12.9 mmHg in one week, and a year long trial lowered resting heart rate by 4 beats per minute.
• Tools: A hand grip trainer costs 20 to 30 dollars, and a pull up bar allows dead hangs, starting at 15 seconds.
• Exceptions: Grip strength and dead hangs are proxies for whole body function and longevity, not proof that nothing else matters.

ZEUS suppressed CRP by the largest margin any anti-inflammatory heart trial has achieved, yet its hazard ratio for cardiovascular events landed at 0.99, a near-exact null result that shows lowering a blood marker doesn't guarantee lowering actual heart attack risk.

• What to do: Don't treat a single CRP reading as proof of high or low cardiovascular inflammation risk on its own; ask your doctor how it fits with your LDL, Lp(a) and overall risk profile instead of reacting to that number in isolation.
• Why it matters: Mendelian randomization studies show genetic variants that change CRP levels don't change cardiovascular disease risk, while variants that change LDL or Lp(a) do, so CRP is a correlated marker of inflammation, not a proven causal driver of heart disease.
• How to apply it: If you have a high Lp(a) on a blood test, know that current Lp(a)-lowering drugs still haven't proven a cardiovascular benefit in a completed phase 3 trial; aggressive LDL management remains the well-proven lever available today.
• Metrics: ZEUS enrolled over 6,300 patients with kidney disease and CRP above 2 mg/L; HORIZON enrolled about 8,300 patients with Lp(a) above 70 mg/dL and lowered Lp(a) by 70 to 80%, likely short of the roughly 100 mg/dL reduction modeling suggested was needed.
• Tools: Newer research is shifting from blood-based markers like CRP toward direct imaging of coronary artery inflammation, such as PET-MRI and CT-based fat attenuation index scans, to select patients more precisely for future anti-inflammatory drug trials.

About a third of people who start carnivore see their LDL cholesterol rise, yet markers like fasting insulin, triglycerides, and hs-CRP staying in normal range matter more for heart risk than that single number, and fiber turns out to be unnecessary since a meal of meat and eggs is fully digested within about two hours.

• What to do: Cover vitamin gaps with two to four ounces of liver a week, or a liver supplement, and track A1C, fasting insulin, triglycerides, HDL, and hs-CRP alongside LDL instead of watching LDL alone.
• Why it matters: The clogged-artery fear comes from a decades-old ad campaign, not physiology, since arteries sit at body temperature and dietary fat never solidifies inside them, and pre-diabetes, obesity, and smoking carry more established heart risk than elevated LDL.
• How to apply it: Treat carnivore as a genuine elimination diet by removing seed oils, grains, and legumes, keep the rendered fat instead of pouring it out, and mix it with a zero-sugar condiment like mustard.
• Metrics: Roughly a third of people see LDL drop, a third stay the same, a third rise, and about 1% spike sharply; meat clears the stomach in around two hours.
• Tools: An organ-based seasoning blend with beef liver and garlic adds about half an ounce of liver to a meal without changing the taste.
• Exceptions: People managing severe autoimmune or inflammatory conditions may skip spices and seasonings for the first 90 to 180 days to rule out triggers.

Without an ApoB particle depositing cholesterol in the artery wall there is no atherosclerosis: it is the necessary substrate, and the single worst gene variant raises cardiovascular risk by under 50 percent while high blood pressure, smoking, or diabetes each multiply it by two to four.

• What to do: Get an Lp(a) once in a lifetime and add an ApoB to your standard lipid panel, along with blood pressure and waist size. If you have high ApoB with a bad family history, consider a low dose statin plus ezetimibe even if imaging shows no plaque.
• Why it matters: Lowering ApoB and LDL cuts events in every trial, and kept cutting them going from 70 to 15 mg/dL. Lower for longer is better, and treatment intensity should match plaque burden.
• How to apply it: Use the PREVENT calculator, which now covers ages 30 to 79 and gives a 30 year risk. A calcium score only sees calcified plaque and coronary CT angiography detects more; a clean coronary does not rule out plaque elsewhere. Re-evaluate yearly and repeat imaging in three to seven years.
• Metrics: physiologic ApoB below 40 to 50 mg/dL, the level we are born with; a threshold of about 5,000 mg/dL years of accumulated LDL cholesterol; example of taking ApoB from 90 to 60 with a low dose statin and ezetimibe; hazard ratio of the worst gene below 1.5.
• Tools: standard lipid panel, ApoB, Lp(a), PREVENT calculator, coronary calcium score, coronary CT angiography, Life's Essential 8, statins, ezetimibe, PCSK9 inhibitors, bempedoic acid.
• Exceptions: you can live to 120 with an untreated LDL of 300 mg/dL and never have an event; the isolated number predicts mainly at the extremes, not in the middle range where most people sit.

In a placebo controlled crossover study of 45 men with low normal testosterone, raising levels from about 310 to 510 ng/dL did nothing for energy, libido or mood that the placebo did not also do, and roughly 70 percent of men who start testosterone quit within a year.

• What to do: Before any prescription, get symptoms plus a confirmed low morning level and a broad workup covering SHBG, free testosterone, thyroid, iron and a sleep apnea screen, and treat reversible causes like visceral fat and poor sleep first.
• Why it matters: A quarter of men starting therapy never had a level drawn and about 1 in 5 tested did not meet criteria, yet only 1 in 10 genuinely deficient men get treated, so the system is misaimed rather than simply over or under prescribing.
• How to apply it: If treatment is warranted, aim for the mid range of 450 to 600 ng/dL measured between doses, use one or two injections per week, and run it as a 3 to 9 month trial you can stop.
• Metrics: TRAVERSE followed more than 5,000 men for two years and found about 7 percent cardiac events in both groups, testosterone and placebo had near identical prostate cancer rates, and a hematocrit above 54 percent is the flag for erythrocytosis.
• Risks: Exogenous testosterone suppresses sperm production and is a leading medically induced cause of male infertility, with recovery of 6 to 12 months or never, so discuss fertility, hCG or clomiphene before the first dose.